SlideShare une entreprise Scribd logo
1  sur  29
Télécharger pour lire hors ligne
1Please excuse me. Someone else needs my attention.
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
1
Innovation at the Point-of-Care:
Rethinking the Doctor-Patient
Encounter
Oct 1, 2013
William Bria, MD
President, AMDIS
Greg Shorr, MD
CMIO, Rover Technologies
Toll, E The Cost of Technology JAMA 307:2497 (2012)
3
The Patient Experience
is always tied to the
User Experience
PX UX
Meaningful Use
vs.
Meaningful Provider-patient Interaction
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
4
5
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
5
6
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
6
7
Patient vs. iPatient
Abraham Verghese, MD
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
7
Rounds vs. iRounds
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
8
Work Habits of the 21st-Century Intern
Block L et al. J Gen Intern Med 2013 Aug
Documentation
= 40%
(Same as in
1989)
Direct Patient
Care = 40%
(20% in 1989)
9
Asynchronous Communication
10
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
11
Clinical Implications of Empathy
and Interpersonal Communication
•Improved Patient Satisfaction
Physician empathy and listening: associations with patient satisfaction
and autonomy
Pollak, KI et al J Am Board Fam Med. 2011 Nov-Dec;24(6):665-72.
•Improved Compliance
The Effects of Physician Empathy on Patient Satisfaction and Compliance
Sung, SK et al Eval Health Prof September 2004 27: 237-251
•Improved Outcomes
The relationship between physician empathy and disease complications
Del Canale, S et al. Acad Med 2012 Sep;87(9):1243-9.
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
12
“The VA’s Center for Innovation (VACI) identifies, tests, and evaluates innovative
solutions to help VA better serve Veterans. We develop programs that nurture
innovation and create an environment where informed risk taking and progressive
thinking are rewarded.”
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
13
VA Innovation project: #5201
“Technology-Enhanced Digital Documentation”
Re-imagine the way clinical information is
managed at the point of service
2012 VHA Innovation Project #5021
• The project was conceived by Dr. Jorge Ferrer who
enlisted Rover Technologies to build and test the
solution
• Voted #20 out of 3,841 VAi2 submissions in 2012
• The project was reviewed and signed off by the VA
leadership including Drs. Petzel and Cullen
• Development will be completed in the VA Sandbox
under the supervision of the VA’s Technical
Director/Sr. Technologist, Bill Cerniuk.
• Deliverables will be tested in VA Usability Labs
14Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
14
Rover’s Innovation
• Objective: Fundamentally Improve the User
Experience (UX) and Patient Experience (PX) at
the Point of Care
• Strategy: Employ disruptive technology to
overcome the intransigence of the UX found on
the current generation of clinical workstations
• Primary Tactic: Take a form-based approach to
digital documentation that emphasizes the
fundamentals of reading and writing
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
15
First Principles
• What is the primary clinical purpose of
the EHR?
– “Tell the Patients Story”
• What is the purpose of clinical
documentation?
– “Fill in knowledge gaps”
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
16
Solution #1: The Story
• Encounter preparation is essential
• When a provider walks into the exam
room, he should look like a genius
– Know the patient as a person
– Know the relevant clinical history
• The only way to accomplish this is for the
provider to review the patient’s “story”
before the encounter
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
17
The quality of the story is the single most
important determinant of the quality of
clinical decision making.
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
18
SUBJECTIVE: The patient is a 66-year-old female who
presents to the clinic today for a five-month recheck on her
type II diabetes mellitus, as well as hypertension. While
here she had a couple of other issues as well. She stated
that she has been having some right shoulder pain. She
denies any injury but certain range of motion does cause it
to hurt. No weakness, numbness or tingling. As far as her
diabetes she states that she only checks her blood sugars
in the morning and those have all been ranging less than
100. She has not been checking any two hours after
meals. Her blood pressures when she does check them
have been running normal as well but she does not have
any record of these present with her. No other issues or
concerns. Upon review of her chart it did show that she
had a benign breast biopsy done back on 06/11/04 and
was told to have a repeat mammogram in six months but
she has never had that done so she is needing to have this
done as well.
ALLERGIES: None.
MEDICATIONS: She is on Hyzaar 50/12.5 one-half p.o.
daily, coated aspirin daily, lovastatin 40 mg one-half tab
p.o. daily, multivitamin daily, metformin 500 mg one tab
p.o. b.i.d.; however, she has been skipping her second
dose during the day.
SOCIAL HISTORY: She is a nonsmoker.
REVIEW OF SYSTEMS: As noted above.
OBJECTIVE:
Vital Signs: Temperature: 98.2. Pulse: 64. Respirations:
16. Blood pressure: 110/56. Weight: 169.
General: Alert and oriented x 3. No acute distress noted.
Neck: No lymphadenopathy, thyromegaly, JVD or bruits.
Lungs: Clear to auscultation.
Heart: Regular rate and rhythm without murmur or gallops
present.
Breasts: Exam performed with a female nurse present.
The breasts do have some scars present underneath
them bilaterally from prior breast reduction surgery.
There is no axillary adenopathy or tenderness. Breasts
appear to be symmetric. There was no nipple discharge
or retraction. Upon palpation there were no palpable
lumps or bumps and no palpable discharge.
Musculoskeletal: She did have full range of motion of her
shoulders. She did have tenderness upon palpation over
the right bicipital tendon. There is no swelling, crepitus or
discoloration noted.
MEDICAL DECISION MAKING: Most recent hemoglobin
A1c was 5.6% back in October 2004. Most recent lipid
checks were obtained back in July 2004. We have not
had this checked since that time.
ASSESSMENT:
1. Type II diabetes mellitus.
2. Hypertension.
3. Right shoulder pain.
4. Hyperlipidemia.
PLAN:
1. She is going to go to lab to obtain a hemoglobin A1c,
BMP, lipids, CPK, liver enzymes and quantitative
microalbumin.
2. We are going to set her up for a diagnostic bilateral
mammogram due to a history of abnormal mammogram
in the past which subsequently showed a benign breast
cyst.
3. I told her for her shoulder to take ibuprofen 600 mg
three times daily with her meals for a minimum of the
next one week.
4. She is going to follow up in the clinic in three months
for a complete comprehensive examination. If any
questions, concerns or problems arise between now and
then she should let us know.
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC 19
20
This is
a story!
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC 20
Storytelling Technology: Automated
Document Assembly
• Turn structured data into unstructured data
• Scenario-specific content dynamically generated at the
time of service
• Transform a “note-oriented” EHR into a “story-oriented”
EHR
• Reduces the intrusive, time-consuming burden of
navigation and thereby facilitates meaninful provider
patient interaction
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
21
Stories
• What is the best time to read the
story?
• Who provides the content; i.e., who
fills in the knowledge gaps?
• Who writes the story?
• Who is the recipient of the story?
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
22
Solution #2: An “Ad Hoc UX”
• Dynamically generated at the point of service
• Unique – intended for a single use (disposable)
• Comfortable
– Adequate amount of real estate
– Essential information on the surface
At the point of service, the focus should be on
1. Interpersonal communication
2. Observation
3. Filling in scenario-specific knowledge gaps –
not formal documentation
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
23
• Encompasses a variety of input modalities:
• Ink is recognized; i.e. converted to
actionable information (e.g., ASCI text)
• This technology is uniquely suited for point
of care documentation.
Enabling Technology: Digital “Ink”
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
24
– Digital pen and paper
– Regular pen and paper
– Tablet PC and Stylus
– Streaming voice recording
– Gestures (e.g., LEAP and
Kinnect
Scratch notes
Drawings and signatures
Check boxes
Streaming Dictation
Workstation control
Workflow control
Long handwritten notes
Digital Writing
at the Point of Care
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
25
Standard pen
Digital pen
Stylus
Voice recorder
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
26
X X
X
X
X
X
X
During
sleep
X
X
W
W
W
WR R
R
R D
D
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
27
Workstation Integration
X
Confidential & Proprietary. All rights reserved to Rover Technologies, LLC.
28
29

Contenu connexe

Similaire à Shorr and bria innovation at the point-of-care rethinking the doctor-patient encounter

NEW Mirror Mirror on the Smartphone.pptx.pdf
NEW Mirror Mirror on the Smartphone.pptx.pdfNEW Mirror Mirror on the Smartphone.pptx.pdf
NEW Mirror Mirror on the Smartphone.pptx.pdfEmily Kunka, MS, CCRP
 
Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...
Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...
Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...Golden Helix
 
Making a Positive Impact on Patient Care: A Case Study of Children’s National...
Making a Positive Impact on Patient Care: A Case Study of Children’s National...Making a Positive Impact on Patient Care: A Case Study of Children’s National...
Making a Positive Impact on Patient Care: A Case Study of Children’s National...Guidon Performance Solutions
 
DIY Diabetes: Lessons for Healthcare
DIY Diabetes: Lessons for HealthcareDIY Diabetes: Lessons for Healthcare
DIY Diabetes: Lessons for HealthcareJoyce Lee
 
Corporate Brochure (WEB)
Corporate Brochure (WEB)Corporate Brochure (WEB)
Corporate Brochure (WEB)Graham Wood
 
Technology will save our minds and bodies
Technology will save our minds and bodiesTechnology will save our minds and bodies
Technology will save our minds and bodiesdavidchraca
 
Your Aging Patient Bed Tower - Top Ten Considerations When Renovating
Your Aging Patient Bed Tower - Top Ten Considerations When RenovatingYour Aging Patient Bed Tower - Top Ten Considerations When Renovating
Your Aging Patient Bed Tower - Top Ten Considerations When RenovatingArray Architects
 
Company presentation
Company presentationCompany presentation
Company presentationsoneerad
 
InnaMed Introducation
InnaMed IntroducationInnaMed Introducation
InnaMed IntroducationInnaMed Inc.
 
Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...
Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...
Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...David Talby
 
Social Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical ResearchSocial Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical ResearchInsideScientific
 
Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar
Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar
Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar PharmaLedger
 
Meaningful use for NYU champions
Meaningful use for NYU championsMeaningful use for NYU champions
Meaningful use for NYU championsleanthonyrn
 
Global Regenerative Academy IA2020.pdf
Global Regenerative Academy IA2020.pdfGlobal Regenerative Academy IA2020.pdf
Global Regenerative Academy IA2020.pdfInnovationStarter
 
Dr. Leigh Anne Poole Lead Follow or Get Out Of The Way
Dr. Leigh Anne Poole Lead Follow or Get Out Of The WayDr. Leigh Anne Poole Lead Follow or Get Out Of The Way
Dr. Leigh Anne Poole Lead Follow or Get Out Of The WaySamantha Haas
 

Similaire à Shorr and bria innovation at the point-of-care rethinking the doctor-patient encounter (20)

NEW Mirror Mirror on the Smartphone.pptx.pdf
NEW Mirror Mirror on the Smartphone.pptx.pdfNEW Mirror Mirror on the Smartphone.pptx.pdf
NEW Mirror Mirror on the Smartphone.pptx.pdf
 
AVICureBiosciencePPT4
AVICureBiosciencePPT4AVICureBiosciencePPT4
AVICureBiosciencePPT4
 
1 (9 files merged).ppt
1 (9 files merged).ppt1 (9 files merged).ppt
1 (9 files merged).ppt
 
Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...
Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...
Maximizing the Benefits of Comprehensive Genomic Testing in Cancer Care with ...
 
Making a Positive Impact on Patient Care: A Case Study of Children’s National...
Making a Positive Impact on Patient Care: A Case Study of Children’s National...Making a Positive Impact on Patient Care: A Case Study of Children’s National...
Making a Positive Impact on Patient Care: A Case Study of Children’s National...
 
DIY Diabetes: Lessons for Healthcare
DIY Diabetes: Lessons for HealthcareDIY Diabetes: Lessons for Healthcare
DIY Diabetes: Lessons for Healthcare
 
Corporate Brochure (WEB)
Corporate Brochure (WEB)Corporate Brochure (WEB)
Corporate Brochure (WEB)
 
Technology will save our minds and bodies
Technology will save our minds and bodiesTechnology will save our minds and bodies
Technology will save our minds and bodies
 
Your Aging Patient Bed Tower - Top Ten Considerations When Renovating
Your Aging Patient Bed Tower - Top Ten Considerations When RenovatingYour Aging Patient Bed Tower - Top Ten Considerations When Renovating
Your Aging Patient Bed Tower - Top Ten Considerations When Renovating
 
Company presentation
Company presentationCompany presentation
Company presentation
 
InnaMed Introducation
InnaMed IntroducationInnaMed Introducation
InnaMed Introducation
 
Non intrusive-devices
Non intrusive-devicesNon intrusive-devices
Non intrusive-devices
 
Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...
Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...
Large Language Models, No-Code, and Responsible AI - Trends in Applied NLP in...
 
Social Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical ResearchSocial Media Data: Opportunities and Insights for Clinical Research
Social Media Data: Opportunities and Insights for Clinical Research
 
Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar
Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar
Clinical Trial eRecruitment | Topic #1 of PharmaLedger's 2nd Open Webinar
 
Cellscan Stanford 2016
Cellscan Stanford 2016Cellscan Stanford 2016
Cellscan Stanford 2016
 
Meaningful use for NYU champions
Meaningful use for NYU championsMeaningful use for NYU champions
Meaningful use for NYU champions
 
Global Regenerative Academy IA2020.pdf
Global Regenerative Academy IA2020.pdfGlobal Regenerative Academy IA2020.pdf
Global Regenerative Academy IA2020.pdf
 
Dr. Leigh Anne Poole Lead Follow or Get Out Of The Way
Dr. Leigh Anne Poole Lead Follow or Get Out Of The WayDr. Leigh Anne Poole Lead Follow or Get Out Of The Way
Dr. Leigh Anne Poole Lead Follow or Get Out Of The Way
 
Gcp 2013
Gcp 2013Gcp 2013
Gcp 2013
 

Plus de Trimed Media Group

Top 5 Sessions to attend at HIMSS.15 (CVB)
Top 5 Sessions to attend at HIMSS.15 (CVB)Top 5 Sessions to attend at HIMSS.15 (CVB)
Top 5 Sessions to attend at HIMSS.15 (CVB)Trimed Media Group
 
Innovative technologies at ACC.15
Innovative technologies at ACC.15Innovative technologies at ACC.15
Innovative technologies at ACC.15Trimed Media Group
 
Imaging at ACC.15: Session Spotlight
Imaging at ACC.15: Session SpotlightImaging at ACC.15: Session Spotlight
Imaging at ACC.15: Session SpotlightTrimed Media Group
 
10 Sessions You Can’t Miss at ACC.15
10 Sessions You Can’t Miss at ACC.1510 Sessions You Can’t Miss at ACC.15
10 Sessions You Can’t Miss at ACC.15Trimed Media Group
 
6 simple tips to help you avoid a lawsuit
6 simple tips to help you avoid a lawsuit6 simple tips to help you avoid a lawsuit
6 simple tips to help you avoid a lawsuitTrimed Media Group
 
Aos 213 01 nelson rivaroxaban effectiveness and safety in nvaf final
Aos 213 01 nelson rivaroxaban effectiveness and safety in nvaf finalAos 213 01 nelson rivaroxaban effectiveness and safety in nvaf final
Aos 213 01 nelson rivaroxaban effectiveness and safety in nvaf finalTrimed Media Group
 
Kuperman Health Information Exchange & Care Coordination
Kuperman Health Information Exchange & Care CoordinationKuperman Health Information Exchange & Care Coordination
Kuperman Health Information Exchange & Care CoordinationTrimed Media Group
 
Safran info sage & disruptive innovation
Safran  info sage & disruptive innovationSafran  info sage & disruptive innovation
Safran info sage & disruptive innovationTrimed Media Group
 
[Hongsermeier] clinical decision support services amdis final
[Hongsermeier] clinical decision support services amdis final[Hongsermeier] clinical decision support services amdis final
[Hongsermeier] clinical decision support services amdis finalTrimed Media Group
 
Hamann big institution to community care
Hamann big institution to community careHamann big institution to community care
Hamann big institution to community careTrimed Media Group
 
Hongsermeier app store for health
Hongsermeier  app store for healthHongsermeier  app store for health
Hongsermeier app store for healthTrimed Media Group
 
Kibbe expect direct health information exchange in the context of state 2 mea...
Kibbe expect direct health information exchange in the context of state 2 mea...Kibbe expect direct health information exchange in the context of state 2 mea...
Kibbe expect direct health information exchange in the context of state 2 mea...Trimed Media Group
 
Crotty engaging patients in new ways from open notes to social media
Crotty  engaging patients in new ways from open notes to social mediaCrotty  engaging patients in new ways from open notes to social media
Crotty engaging patients in new ways from open notes to social mediaTrimed Media Group
 
Karson approaching innovation with commercial ehrs
Karson approaching innovation with commercial ehrsKarson approaching innovation with commercial ehrs
Karson approaching innovation with commercial ehrsTrimed Media Group
 

Plus de Trimed Media Group (20)

HRS.15 Sessions to Attend
HRS.15 Sessions to AttendHRS.15 Sessions to Attend
HRS.15 Sessions to Attend
 
Himss cvb sessions
Himss cvb sessionsHimss cvb sessions
Himss cvb sessions
 
Top 5 Sessions to attend at HIMSS.15 (CVB)
Top 5 Sessions to attend at HIMSS.15 (CVB)Top 5 Sessions to attend at HIMSS.15 (CVB)
Top 5 Sessions to attend at HIMSS.15 (CVB)
 
Innovative technologies at ACC.15
Innovative technologies at ACC.15Innovative technologies at ACC.15
Innovative technologies at ACC.15
 
Imaging at ACC.15: Session Spotlight
Imaging at ACC.15: Session SpotlightImaging at ACC.15: Session Spotlight
Imaging at ACC.15: Session Spotlight
 
10 Sessions You Can’t Miss at ACC.15
10 Sessions You Can’t Miss at ACC.1510 Sessions You Can’t Miss at ACC.15
10 Sessions You Can’t Miss at ACC.15
 
6 simple tips to help you avoid a lawsuit
6 simple tips to help you avoid a lawsuit6 simple tips to help you avoid a lawsuit
6 simple tips to help you avoid a lawsuit
 
RSNA 2014
RSNA 2014RSNA 2014
RSNA 2014
 
Aos 213 01 nelson rivaroxaban effectiveness and safety in nvaf final
Aos 213 01 nelson rivaroxaban effectiveness and safety in nvaf finalAos 213 01 nelson rivaroxaban effectiveness and safety in nvaf final
Aos 213 01 nelson rivaroxaban effectiveness and safety in nvaf final
 
Acep 10-15-13
Acep 10-15-13Acep 10-15-13
Acep 10-15-13
 
Kuperman Health Information Exchange & Care Coordination
Kuperman Health Information Exchange & Care CoordinationKuperman Health Information Exchange & Care Coordination
Kuperman Health Information Exchange & Care Coordination
 
Safran info sage & disruptive innovation
Safran  info sage & disruptive innovationSafran  info sage & disruptive innovation
Safran info sage & disruptive innovation
 
[Hongsermeier] clinical decision support services amdis final
[Hongsermeier] clinical decision support services amdis final[Hongsermeier] clinical decision support services amdis final
[Hongsermeier] clinical decision support services amdis final
 
[Teich] amdis
[Teich] amdis[Teich] amdis
[Teich] amdis
 
Hamann big institution to community care
Hamann big institution to community careHamann big institution to community care
Hamann big institution to community care
 
Hongsermeier app store for health
Hongsermeier  app store for healthHongsermeier  app store for health
Hongsermeier app store for health
 
Mandl app store for health
Mandl  app store for healthMandl  app store for health
Mandl app store for health
 
Kibbe expect direct health information exchange in the context of state 2 mea...
Kibbe expect direct health information exchange in the context of state 2 mea...Kibbe expect direct health information exchange in the context of state 2 mea...
Kibbe expect direct health information exchange in the context of state 2 mea...
 
Crotty engaging patients in new ways from open notes to social media
Crotty  engaging patients in new ways from open notes to social mediaCrotty  engaging patients in new ways from open notes to social media
Crotty engaging patients in new ways from open notes to social media
 
Karson approaching innovation with commercial ehrs
Karson approaching innovation with commercial ehrsKarson approaching innovation with commercial ehrs
Karson approaching innovation with commercial ehrs
 

Dernier

ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 

Dernier (20)

GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 

Shorr and bria innovation at the point-of-care rethinking the doctor-patient encounter

  • 1. 1Please excuse me. Someone else needs my attention. Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 1
  • 2. Innovation at the Point-of-Care: Rethinking the Doctor-Patient Encounter Oct 1, 2013 William Bria, MD President, AMDIS Greg Shorr, MD CMIO, Rover Technologies
  • 3. Toll, E The Cost of Technology JAMA 307:2497 (2012) 3
  • 4. The Patient Experience is always tied to the User Experience PX UX Meaningful Use vs. Meaningful Provider-patient Interaction Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 4
  • 5. 5 Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 5
  • 6. 6 Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 6
  • 7. 7 Patient vs. iPatient Abraham Verghese, MD Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 7
  • 8. Rounds vs. iRounds Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 8
  • 9. Work Habits of the 21st-Century Intern Block L et al. J Gen Intern Med 2013 Aug Documentation = 40% (Same as in 1989) Direct Patient Care = 40% (20% in 1989) 9
  • 11. Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 11
  • 12. Clinical Implications of Empathy and Interpersonal Communication •Improved Patient Satisfaction Physician empathy and listening: associations with patient satisfaction and autonomy Pollak, KI et al J Am Board Fam Med. 2011 Nov-Dec;24(6):665-72. •Improved Compliance The Effects of Physician Empathy on Patient Satisfaction and Compliance Sung, SK et al Eval Health Prof September 2004 27: 237-251 •Improved Outcomes The relationship between physician empathy and disease complications Del Canale, S et al. Acad Med 2012 Sep;87(9):1243-9. Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 12
  • 13. “The VA’s Center for Innovation (VACI) identifies, tests, and evaluates innovative solutions to help VA better serve Veterans. We develop programs that nurture innovation and create an environment where informed risk taking and progressive thinking are rewarded.” Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 13 VA Innovation project: #5201 “Technology-Enhanced Digital Documentation” Re-imagine the way clinical information is managed at the point of service
  • 14. 2012 VHA Innovation Project #5021 • The project was conceived by Dr. Jorge Ferrer who enlisted Rover Technologies to build and test the solution • Voted #20 out of 3,841 VAi2 submissions in 2012 • The project was reviewed and signed off by the VA leadership including Drs. Petzel and Cullen • Development will be completed in the VA Sandbox under the supervision of the VA’s Technical Director/Sr. Technologist, Bill Cerniuk. • Deliverables will be tested in VA Usability Labs 14Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 14
  • 15. Rover’s Innovation • Objective: Fundamentally Improve the User Experience (UX) and Patient Experience (PX) at the Point of Care • Strategy: Employ disruptive technology to overcome the intransigence of the UX found on the current generation of clinical workstations • Primary Tactic: Take a form-based approach to digital documentation that emphasizes the fundamentals of reading and writing Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 15
  • 16. First Principles • What is the primary clinical purpose of the EHR? – “Tell the Patients Story” • What is the purpose of clinical documentation? – “Fill in knowledge gaps” Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 16
  • 17. Solution #1: The Story • Encounter preparation is essential • When a provider walks into the exam room, he should look like a genius – Know the patient as a person – Know the relevant clinical history • The only way to accomplish this is for the provider to review the patient’s “story” before the encounter Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 17
  • 18. The quality of the story is the single most important determinant of the quality of clinical decision making. Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 18
  • 19. SUBJECTIVE: The patient is a 66-year-old female who presents to the clinic today for a five-month recheck on her type II diabetes mellitus, as well as hypertension. While here she had a couple of other issues as well. She stated that she has been having some right shoulder pain. She denies any injury but certain range of motion does cause it to hurt. No weakness, numbness or tingling. As far as her diabetes she states that she only checks her blood sugars in the morning and those have all been ranging less than 100. She has not been checking any two hours after meals. Her blood pressures when she does check them have been running normal as well but she does not have any record of these present with her. No other issues or concerns. Upon review of her chart it did show that she had a benign breast biopsy done back on 06/11/04 and was told to have a repeat mammogram in six months but she has never had that done so she is needing to have this done as well. ALLERGIES: None. MEDICATIONS: She is on Hyzaar 50/12.5 one-half p.o. daily, coated aspirin daily, lovastatin 40 mg one-half tab p.o. daily, multivitamin daily, metformin 500 mg one tab p.o. b.i.d.; however, she has been skipping her second dose during the day. SOCIAL HISTORY: She is a nonsmoker. REVIEW OF SYSTEMS: As noted above. OBJECTIVE: Vital Signs: Temperature: 98.2. Pulse: 64. Respirations: 16. Blood pressure: 110/56. Weight: 169. General: Alert and oriented x 3. No acute distress noted. Neck: No lymphadenopathy, thyromegaly, JVD or bruits. Lungs: Clear to auscultation. Heart: Regular rate and rhythm without murmur or gallops present. Breasts: Exam performed with a female nurse present. The breasts do have some scars present underneath them bilaterally from prior breast reduction surgery. There is no axillary adenopathy or tenderness. Breasts appear to be symmetric. There was no nipple discharge or retraction. Upon palpation there were no palpable lumps or bumps and no palpable discharge. Musculoskeletal: She did have full range of motion of her shoulders. She did have tenderness upon palpation over the right bicipital tendon. There is no swelling, crepitus or discoloration noted. MEDICAL DECISION MAKING: Most recent hemoglobin A1c was 5.6% back in October 2004. Most recent lipid checks were obtained back in July 2004. We have not had this checked since that time. ASSESSMENT: 1. Type II diabetes mellitus. 2. Hypertension. 3. Right shoulder pain. 4. Hyperlipidemia. PLAN: 1. She is going to go to lab to obtain a hemoglobin A1c, BMP, lipids, CPK, liver enzymes and quantitative microalbumin. 2. We are going to set her up for a diagnostic bilateral mammogram due to a history of abnormal mammogram in the past which subsequently showed a benign breast cyst. 3. I told her for her shoulder to take ibuprofen 600 mg three times daily with her meals for a minimum of the next one week. 4. She is going to follow up in the clinic in three months for a complete comprehensive examination. If any questions, concerns or problems arise between now and then she should let us know. Confidential & Proprietary. All rights reserved to Rover Technologies, LLC 19
  • 20. 20 This is a story! Confidential & Proprietary. All rights reserved to Rover Technologies, LLC 20
  • 21. Storytelling Technology: Automated Document Assembly • Turn structured data into unstructured data • Scenario-specific content dynamically generated at the time of service • Transform a “note-oriented” EHR into a “story-oriented” EHR • Reduces the intrusive, time-consuming burden of navigation and thereby facilitates meaninful provider patient interaction Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 21
  • 22. Stories • What is the best time to read the story? • Who provides the content; i.e., who fills in the knowledge gaps? • Who writes the story? • Who is the recipient of the story? Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 22
  • 23. Solution #2: An “Ad Hoc UX” • Dynamically generated at the point of service • Unique – intended for a single use (disposable) • Comfortable – Adequate amount of real estate – Essential information on the surface At the point of service, the focus should be on 1. Interpersonal communication 2. Observation 3. Filling in scenario-specific knowledge gaps – not formal documentation Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 23
  • 24. • Encompasses a variety of input modalities: • Ink is recognized; i.e. converted to actionable information (e.g., ASCI text) • This technology is uniquely suited for point of care documentation. Enabling Technology: Digital “Ink” Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 24 – Digital pen and paper – Regular pen and paper – Tablet PC and Stylus – Streaming voice recording – Gestures (e.g., LEAP and Kinnect
  • 25. Scratch notes Drawings and signatures Check boxes Streaming Dictation Workstation control Workflow control Long handwritten notes Digital Writing at the Point of Care Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 25 Standard pen Digital pen Stylus Voice recorder
  • 26. Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 26
  • 27. X X X X X X X During sleep X X W W W WR R R R D D Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 27
  • 28. Workstation Integration X Confidential & Proprietary. All rights reserved to Rover Technologies, LLC. 28
  • 29. 29